메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 27, Issue 13, 2009, Pages 2296-2297
Prophylactic intravenous immunoglobulin does not have a role in hematopoietic stem-cell transplantation: Is the evidence clear?
Author keywords

[No Author keywords available]
Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT;
EID: 65549135762     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.0897     Document Type: Letter
Times cited : (3)
References (6)
  • 1
    • 59949103959 scopus 로고    scopus 로고
    • Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: Systematic review and meta-analysis
    • Raanani P, Gafter-Gvili A, Paul M, et al: Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: Systematic review and meta-analysis. J Clin Oncol 27:770-781, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 770-781
    • Raanani, P.1    Gafter-Gvili, A.2    Paul, M.3
  • 2
    • 59949097531 scopus 로고    scopus 로고
    • Clinical effects of intravenous immune globulin (IVIG) treatment in patients with allogeneic peripheral stem cell transplantation
    • Ustun C, Ozcan M, Beksac M, et al: Clinical effects of intravenous immune globulin (IVIG) treatment in patients with allogeneic peripheral stem cell transplantation. Blood 92:355b, 1998
    • (1998) Blood , vol.92
    • Ustun, C.1    Ozcan, M.2    Beksac, M.3
  • 3
    • 0026632421 scopus 로고
    • Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation
    • Poynton CH, Jackson S, Fegan C, et al: Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplant 9:451-457, 1992
    • (1992) Bone Marrow Transplant , vol.9 , pp. 451-457
    • Poynton, C.H.1    Jackson, S.2    Fegan, C.3
  • 4
    • 0038819950 scopus 로고    scopus 로고
    • Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial
    • Cordonnier C, Chevret S, Legrand M, et al: Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 139:8-18, 2003
    • (2003) Ann Intern Med , vol.139 , pp. 8-18
    • Cordonnier, C.1    Chevret, S.2    Legrand, M.3
  • 5
    • 33750081766 scopus 로고    scopus 로고
    • Stem cell transplantation with reduced-intensity conditioning regimens: A review of ten years experience with new transplant concepts and new therapeutic agents
    • Barrett AJ, Savani BN: Stem cell transplantation with reduced-intensity conditioning regimens: A review of ten years experience with new transplant concepts and new therapeutic agents. Leukemia 20:1661-1672, 2006
    • (2006) Leukemia , vol.20 , pp. 1661-1672
    • Barrett, A.J.1    Savani, B.N.2
  • 6
    • 84921537511 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation: Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
    • CE1-7
    • Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation: Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49:1-125, CE1-7, 2000
    • (2000) MMWR Recomm Rep , vol.49 , pp. 1-125

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.